AZN

AstraZeneca PLC (AZN)

Last Price$74.20.9%
Market Cap$460.2B
LTM FCF to Net Income
88.5%
5Y avg
14.9%
Drug Manufacturers - General industry median
88.5%
Stock quality & Intrinsic value
7/10
(0.6%) overvalued

AstraZeneca PLC FCF to Net Income

Annual
Quarterly
LTM
Industry median
Company stand-alone
AZN
Healthcare
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
FCF to Net Income
99.9%
88.6%
77.3%
72.0%
51.4%
116.8%
75.2%
52.8%
30.2%
163.5%
345.6%
17.5%
51.5%
87.9%
62.6%
32.9%
56.0%
(1,420.0%)
289.4%
95.2%
AZN
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for AZN and see if it's the right time to invest.
Dive in

AstraZeneca PLC (AZN) FCF to Net Income comparison analysis

Crunching data... Almost there!

AZN key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is AstraZeneca PLC's FCF to Net Income?

As of today, Microsoft Corp's last 12-month FCF to Net Income is 88.5%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual FCF to Net Income for AstraZeneca PLC have been (4.6%) over the past three years, and 15.7% over the past five years.

2) Is AstraZeneca PLC's FCF to Net Income Good?

As of today, AstraZeneca PLC's FCF to Net Income is 88.5%, which is lower than industry median of 88.5%. It indicates that AstraZeneca PLC's FCF to Net Income is Bad.

3) How does AstraZeneca PLC's FCF to Net Income compare to its peers?

As of today, AstraZeneca PLC's FCF to Net Income is 88.5%, which is higher than peer median of 70.6%. The list of peers includes ABBV, AMGN, JNJ, NVS, MRK, PFE, LLY, SNY, BMY, GILD.